Veterinary Medicines

ORNIVAC ND+IB2+EDS, injekční emulze pro kura domácího, Injekční emulze

Authorised
  • Newcastle disease virus, strain SL-93, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Avian infectious bronchitis virus, strain D274, Inactivated
  • Eggdrop syndrome-1976 virus, Inactivated
Download as PDF

Product identification

Medicine name:
ORNIVAC ND+IB2+EDS, injekční emulze pro kura domácího, Injekční emulze
Active substance:
  • Newcastle disease virus, strain SL-93, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Avian infectious bronchitis virus, strain D274, Inactivated
  • Eggdrop syndrome-1976 virus, Inactivated
Target species:
  • Chicken (pullet)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Newcastle disease virus, strain SL-93, Inactivated
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    6.20
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, strain D274, Inactivated
    6.30
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Eggdrop syndrome-1976 virus, Inactivated
    6.50
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken (pullet)
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/003/14-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 14/02/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 14/02/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 12/05/2025
Download